Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients

NCT00428922 is registered in ClinicalTrials.gov with Bhuvaneswari Ramaswamy as lead sponsor.

NCT NCT00428922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00428922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients
Lead sponsor
Bhuvaneswari Ramaswamy
Phase
Phase 2
Overall status
Completed
Start date
June 14, 2007
Completion date
February 7, 2017
Enrollment
26 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer